Patents Assigned to Goldfinch Bio, Inc.
  • Patent number: 11623930
    Abstract: Disclosed are compounds according to Formula (I) or (II), and pharmaceutical compositions comprising them. Also disclosed are therapeutic methods, e.g., of treating kidney diseases, using the compounds of Formula (I) or (II).
    Type: Grant
    Filed: March 5, 2019
    Date of Patent: April 11, 2023
    Assignee: Goldfinch Bio, Inc.
    Inventors: Matthew H. Daniels, Maolin Yu, Jean-Christophe P. Harmange, Thomas T. Tibbitts, Mark W. Ledeboer, Neil A. Castle, Goran Malojcic
  • Patent number: 11046690
    Abstract: Disclosed are compounds according to Formula (I), and related pharmaceutical compositions. Also disclosed are therapeutic methods, e.g., of treating kidney diseases, using the compounds of Formula (I).
    Type: Grant
    Filed: May 18, 2020
    Date of Patent: June 29, 2021
    Assignee: Goldfinch Bio, Inc.
    Inventors: Mark W. Ledeboer, Matthew H. Daniels, Maolin Yu, Jean-Christophe P. Harmange
  • Publication number: 20210115036
    Abstract: Disclosed are compounds according to Formula (I) or (II), and pharmaceutical compositions comprising them. Also disclosed are therapeutic methods, e.g., of treating kidney diseases, using the compounds of Formula (I) or (II).
    Type: Application
    Filed: August 3, 2018
    Publication date: April 22, 2021
    Applicant: Goldfinch Bio, Inc.
    Inventors: Mark W. Ledeboer, Jean-Christophe P. Harmange, Thomas T. Tibbitts
  • Patent number: 10654850
    Abstract: Disclosed are compounds according to Formula (I), and related pharmaceutical compositions. Also disclosed are therapeutic methods, e.g., of treating kidney diseases, using the compounds of Formula (I).
    Type: Grant
    Filed: September 18, 2019
    Date of Patent: May 19, 2020
    Assignee: Goldfinch Bio, Inc.
    Inventors: Mark W. Ledeboer, Matthew H. Daniels, Maolin Yu, Jean-Christophe P. Harmange